2023
Associations Between Long-Term Air Pollutant Exposure and 30-Day All-Cause Hospital Readmissions in US Patients With Stroke
Tran P, Warren J, Leifheit E, Goldstein L, Lichtman J. Associations Between Long-Term Air Pollutant Exposure and 30-Day All-Cause Hospital Readmissions in US Patients With Stroke. Stroke 2023, 54: e126-e129. PMID: 36729388, PMCID: PMC11059199, DOI: 10.1161/strokeaha.122.042265.Peer-Reviewed Original ResearchConceptsLong-term air pollutant exposureAir pollutant exposureCause hospital readmissionHospital readmissionPollutant exposureMedicare beneficiaries agePerformance categoriesMatter 2.5Sulfur dioxide exposureCause readmission measureIschemic strokeStroke incidenceUS patientsHospital characteristicsSD increaseReadmissionCox modelReadmission measuresBeneficiaries ageLong-term exposureStrokePatientsMedicaid ServicesParticulate matter 2.5US fee
2021
Adherence to Acute Care Measures Affects Mortality in Patients with Ischemic Stroke: The Florida Stroke Registry
Gardener H, Rundek T, Lichtman J, Leifheit E, Wang K, Asdaghi N, Romano JG, Sacco RL. Adherence to Acute Care Measures Affects Mortality in Patients with Ischemic Stroke: The Florida Stroke Registry. Journal Of Stroke And Cerebrovascular Diseases 2021, 30: 105586. PMID: 33412397, PMCID: PMC7880890, DOI: 10.1016/j.jstrokecerebrovasdis.2020.105586.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overFemaleFibrinolytic AgentsFloridaGuideline AdherenceHealthcare DisparitiesHospital MortalityHumansHydroxymethylglutaryl-CoA Reductase InhibitorsIschemic StrokeMaleMedicarePatient ReadmissionPractice Guidelines as TopicPractice Patterns, Physicians'Quality ImprovementQuality Indicators, Health CareRegistriesRisk AssessmentRisk FactorsRisk Reduction BehaviorSmoking CessationThrombolytic TherapyTime FactorsTreatment OutcomeUnited StatesConceptsAcute care measuresFlorida Stroke RegistryHospital readmissionCare measuresStatin therapyRace/ethnicityStroke RegistryAntithrombotic therapyIschemic strokeAntithrombotic useStroke careIntravenous alteplase treatmentMedicare beneficiaries ageAcute stroke careIschemic stroke patientsLong-term mortalityVascular risk factorsRace/ethnic disparitiesFull study populationAlteplase treatmentDVT prophylaxisEligible patientsAnticoagulation therapyCessation counselingStatin use